A town between two cities, and what that means for care
Plant City has a strong identity, the winter strawberry town whose Strawberry Festival draws crowds from all over Florida every year, and a thinner bench of local clinical options than either of its neighbors. Residents already know the drill for anything specialized: you look west toward Brandon and Tampa or east toward Lakeland, because the deep medical infrastructure sits at both ends rather than in the middle.
Cannabis certification followed a different and less useful pattern. Storefront operations showed up because the quick-visit model requires almost no medical infrastructure at all, so what Plant City got locally looks like what Lakeland and Brandon got, volume operations moving patients through in minutes. What the town didn't get is the thing a certification actually calls for, which is a physician who reads your chart before signing anything.
That's the gap Ascend fills from the Tampa end. Our Tampa-Carrollwood office at 3971 Moran Road anchors a real practice, and Plant City patients are welcome to treat it as their own. It's also worth knowing the same practice runs primary care, psychiatry, and talk therapy lines, so the certification visit can connect to broader care when you want it to, much of it available by telehealth afterward.
Continuity is the quiet advantage in that arrangement. A card renews for years, and over those years medications change, conditions evolve, and new diagnoses show up. When the practice that certified you also handles chronic disease management, those changes get folded into the renewal conversation instead of slipping past a stranger who sees you once every 210 days and knows nothing in between. For a town that has always found its specialists outside the town line, anchoring that continuity inside a full practice is a reasonable trade.
One in-person visit, and what the statute requires
The initial evaluation happens in person at the Tampa-Carrollwood office, 3971 Moran Road, Suite 101, Tampa, FL 33618. Florida law is the reason it cannot be remote. The statute requires an in-person evaluation with the qualifying physician before any initial Compassionate Use Registry entry, so a website advertising a first-time card with no office visit is advertising around the law. Patients reach us from across eastern Hillsborough and beyond it: Dover, Lithia, Mulberry, Brandon, and the Plant City ZIP codes 33563 through 33567.
What the law does permit is telehealth for most follow-ups. Certifications renew on the state's 210-day interval, and those renewal appointments can usually happen by video, as long as you are physically in Florida during the appointment. Booking starts at (863) 510-2624. A telehealth renewal asks very little of you technically: any device with a camera and a decent connection works, and the appointment covers how the treatment has performed since last time, what has changed in your health, and whether continuing still makes clinical sense. Renewals are not rubber stamps here, which is the point.
Caregivers, patients under 18, and the second-physician rule
Two parts of Florida's statute get almost no attention in certification advertising, because neither one can be handled in fifteen minutes. Both come up often enough in a family practice to be worth setting out plainly.
The first is the caregiver. Florida allows a qualified patient to register a caregiver who can purchase and possess cannabis on the patient's behalf, which matters for a patient who is too ill, too impaired, or otherwise unable to manage the visits to a treatment center themselves. A caregiver is not an informal arrangement between family members. Under current rules a caregiver must be at least 21, must register with the Office of Medical Marijuana Use and hold their own state-issued caregiver identification card, and must complete the state's caregiver requirements. Caregivers may not be qualifying physicians and may not be employed by or hold an economic interest in a treatment center, and the number of patients one caregiver may assist is limited, with exceptions the department applies for close relatives. A caregiver purchases and transports on the patient's behalf; the product is for the patient, not the caregiver.
The second is the pathway for patients under 18. Florida's statute does contemplate minors, but it puts additional structure around them: a concurring opinion from a second qualified physician, a registered caregiver rather than a self-managing patient, and route restrictions that do not apply to adults. That is a deliberately higher bar, and it exists because the evidence and the risk profile in a developing brain are not the adult picture.
Ascend's certification evaluations are limited to adults 18 and older. If you are a parent reading this page for a child, we would rather say that clearly than take the appointment and refer you out afterward. The right next step is a physician who performs pediatric certifications alongside the specialist already managing the underlying condition, and if the underlying condition is psychiatric, our psychiatry team can be part of that conversation even when the certification itself is not ours to make.
A related provision covers terminal conditions, where the statute also requires a diagnosis from a physician other than the qualifying physician before certification. It is the same principle in a different place: where the stakes or the vulnerability rise, the law asks for a second set of eyes. We confirm all of these requirements against the current statute and department rule at the visit, because Florida has revised this framework before and can again.
How certification actually works, start to finish
The visit itself runs 30 to 45 minutes with Dr. Saylor, an osteopathic family medicine physician who is board certified, has 17 years of clinical experience, and serves as Chief Medical Officer at Ascend. Bring documentation of the condition you believe qualifies: specialist notes, imaging, prior medication trials, related diagnoses. He'll go through your history, your current medications and their interaction risks, what you've already tried for the condition, and what the research does and doesn't say about cannabis for your situation. Cannabis is never the first tool off the shelf, and the visit treats it as one option inside a larger plan, weighed against and alongside standard treatments.
If certification is clinically appropriate and the statute is satisfied, the recommendation enters the Compassionate Use Registry at that same appointment. The next steps happen from home: you submit the patient application through the Office of Medical Marijuana Use website, pay the state's fee directly to the OMMU, and wait out processing, which typically takes a few weeks. Card in hand, you can buy from any licensed Medical Marijuana Treatment Center in Florida.
If certification isn't appropriate, you'll be told exactly that and exactly why. Missing documentation, a condition outside the statute, a safety concern with your current medications, whichever it is, the reason comes with a plan for what to do instead. Coordination with our psychiatry and talk therapy teams happens inside the same practice when the underlying condition needs more than a card.
One thing the visit deliberately does not include is product selection. Florida draws a hard line there: the physician certifies and sets the framework in the registry, and the dispensary handles products under its own state licensing. What Dr. Saylor will discuss is the clinical side of that boundary, meaning routes of administration, the practical difference between THC-dominant and CBD-dominant approaches, and how to start conservatively and adjust slowly. What he won't do is steer you to a brand or a store, because that isn't the physician's lane and shouldn't be.
Who qualifies under the statute, and who doesn't
The controlling law is Section 381.986, Florida Statutes. Its qualifying list currently covers cancer, epilepsy, glaucoma, HIV/AIDS, PTSD, amyotrophic lateral sclerosis, Crohn's disease, Parkinson's disease, multiple sclerosis, conditions of the same kind or class as those listed, terminal conditions diagnosed by a physician other than the certifying one, and chronic nonmalignant pain that is caused by or originates from a qualifying condition. Because the legislature can revise the list, we check your eligibility against the statute as it stands on the day of your evaluation.
The two most common misunderstandings we untangle both involve documentation. Chronic pain by itself doesn't qualify; the statute wants pain traceable to a qualifying condition, with records showing the connection. And a PTSD certification requires an actual documented diagnosis, which many people seeking one don't yet have. When that's the case, our psychiatric team can perform the evaluation properly first, and the certification question waits its turn. Specialist conditions follow the same logic: the neurologist's, gastroenterologist's, or oncologist's records are what give the visit something to stand on. As for "same kind or class," that phrase gets stretched hard in advertising, but in practice it's a case-by-case physician judgment measured against the listed conditions.
Worth adding: a no today isn't necessarily a no forever. Plenty of patients leave a first conversation with homework, a psychiatric evaluation to schedule, imaging to complete, records to request from an old provider, and come back with a file the statute can actually work with. We'd rather build the case properly than stretch a definition and hope nobody looks.
Straight talk on the evidence and the FDA
Honesty about the research is part of the service, so here it is in compressed form. The strongest findings, per the National Academies of Sciences' 2017 consensus report, are substantial evidence for cannabis or cannabinoids in adult chronic pain and in chemotherapy-induced nausea and vomiting, with moderate evidence for spasticity in multiple sclerosis. After that the evidence thins quickly; the same report rated many popular uses limited or insufficient, and long-term outcome data is sparse across the board. PTSD research remains mixed, a fact worth sitting with since PTSD accounts for so many Florida certifications.
The regulatory picture is unambiguous. Cannabis remains a Schedule I controlled substance federally, the FDA has approved no smoked or raw cannabis product for any condition, and the only FDA-approved cannabis-derived prescription is a purified CBD medication for certain rare seizure disorders that has nothing to do with dispensary inventory. Individual responses vary, side effects and drug interactions are genuine, and no honest clinic can guarantee approval or benefit. That sentence stays on every page we publish about this program because it's true.
Impairment, firearms, and the parts that outrank state law
A registry card gives you standing under Florida law and nothing beyond it, and several doors swing the other way. Behind the wheel: impairment is impairment, and a medical card is not a defense against a Florida DUI charge. Firearms: federal law at 18 U.S.C. § 922(g)(3) bars users of federally controlled substances from buying or possessing guns, and the ATF purchase form asks about marijuana with no carve-out for state medical programs. Work: Florida's program doesn't require any employer to accommodate cannabis use, a card generally won't save you from a failed drug test, and federally regulated testing regimes, commercial transport among them, don't recognize state medical cards at all. Florida also prohibits growing your own, and the card means nothing on federal property or in states that don't honor it.
We'd rather you weigh all of that before applying than discover it afterward. Evaluations are limited to adults 18 and older, and this page is educational information, not legal advice.
Two payments, two different recipients
There are two costs and they flow to two different places. The clinical evaluation fee goes to the practice, and rather than publishing numbers that go stale, we have the medical billing team confirm current rates for evaluations, follow-ups, and renewals when you call (813) 670-3331. The state ID card application fee goes straight to the OMMU during your online application and is never part of our visit fee.
Plan on self-pay for the certification visit. The federal Schedule I status keeps most insurers away from anything labeled a cannabis evaluation, whatever Florida's program says, so coverage is the rare exception rather than the rule. Where the clinical picture legitimately supports it, the underlying chronic disease management visit, say a chronic pain or PTSD workup, can sometimes be billed to insurance as its own encounter, separate from the certification. HSA and FSA cards deserve a call to your plan administrator first, since cannabis exclusions are written into many plans.
When you do call, the billing conversation should leave nothing fuzzy. You'll get the rate for the visit type you actually need, initial evaluation versus renewal, a clear statement of what the state charges separately for the ID card, and an honest answer about whether any part of your situation supports insurance billing for the underlying condition. If a clinic anywhere quotes you one bundled number and waves off the details, that's worth noticing. For scheduling the evaluation itself, Plant City patients book at (863) 510-2624.
Work comes up more often here, so we start there
Plant City's working life leans toward agriculture, logistics, and the warehousing and freight that spread east out of Tampa. Those are industries with testing programs, equipment operation, and federal oversight threaded through them, which makes the occupational conversation less optional here than it might be elsewhere.
Most certification advertising does not go anywhere near this. It is easier to sell a card than to explain that the card sits underneath a federal system that does not acknowledge it. But a patient who loses a commercial license over a decision nobody explained has not been well served, however clinically reasonable the certification was.
So on this page the work question comes before the evidence discussion, rather than after it. For a meaningful number of readers here it is the fact that decides the whole thing, and burying it under six paragraphs about the statute would be a strange way to treat the most consequential piece of information we have.
What we can tell you, and what we cannot
We can tell you what Florida law does and does not do, what the federal position is, and how the two interact in the general case. We can tell you honestly whether a qualifying condition is documented and whether cannabis is a reasonable thing to consider for it. That is medicine, and it is our job.
We cannot read your employment contract, interpret your union agreement, or predict how a specific employer will handle a specific test result. A clinic that offers those assurances is exceeding what it actually knows. When the question is genuinely an employment law question, we will say so and point you toward someone qualified to answer it, which is a less satisfying response than a confident one and a considerably more useful one.
Related care and nearby areas
- The medical marijuana program: how the program works across the practice
- Valrico certification: the neighboring page to the west
- Brandon certification: with more on gathering specialist records
- Chronic pain: evaluation, and the treatments that are not cannabis
- Primary care: the ongoing care this decision belongs inside
- Psychiatry: for psychiatric qualifying conditions
FAQs about medical marijuana evaluation in Plant City
What are Florida's qualifying conditions?
Florida law lists specific qualifying conditions, including cancer, epilepsy, glaucoma, HIV/AIDS, PTSD, ALS, Crohn's disease, Parkinson's disease, multiple sclerosis, medical conditions of the same kind or class, terminal conditions, and chronic nonmalignant pain caused by or originating from a qualifying medical condition. The list can change as state law evolves; we confirm eligibility at your evaluation based on current statute.
Where is the Plant City evaluation done?
The initial Compassionate Use Registry evaluation is done in-person per Florida law at our Tampa-Carrollwood office (3971 Moran Road, Suite 101, Tampa, FL 33618). Ascend has no office in Plant City. Follow-up visits can often be done via telehealth.
Will a medical marijuana card affect my job?
It can, and this is the question we would want asked before certification rather than after. A Florida card changes your standing under state health law. It does not override an employer's drug-free workplace policy, and Florida employers generally retain the right to enforce those policies regardless of your certification status. Whether that matters to you depends entirely on where you work, which is why we raise it in the room.
I hold a CDL. Does certification change anything?
Commercial drivers fall under federal testing rules, and federal law does not recognize state medical marijuana programs. A state card provides no protection in that system. If your livelihood depends on a commercial license, that is a significant consideration and one worth weighing carefully, including with your employer or an employment attorney, before anything is entered in the registry.
What about safety-sensitive work and federal contractors?
The same principle applies and it is a broad category around here: transportation, heavy equipment, warehousing, anything under a federal contract, and many roles that carry a testing requirement written into the job. State certification does not create an exemption from those requirements. We will name the exposure honestly rather than leaving you to discover it at a test.
Will my employer be told that I was certified?
We do not notify employers. The registry is a state health record rather than a public list, and your evaluation is a medical visit like any other. What we cannot do is predict how a workplace testing program interacts with your particular situation, so if the stakes are high, your own HR policy and, where warranted, an employment attorney are the right sources rather than a clinic.
Should I talk to anyone before I book the appointment?
If you work in a tested or safety-sensitive role, yes. Read your own workplace policy first. It costs you nothing and it is the single most useful preparation a Plant City patient can do, because it turns an abstract worry into a specific fact you can weigh against the clinical benefit.
Does any of this make certification a bad idea?
Not by itself. Plenty of patients weigh the occupational tradeoffs, decide the clinical benefit is worth it, and proceed with clear eyes, which is exactly the point of naming them. Others decide the exposure is too high for their situation and we look at other options for the underlying condition instead. Both are legitimate endings to an honest conversation.
Sources
- Florida Statute § 381.986 (medical use of marijuana)
- Florida Department of Health, Office of Medical Marijuana Use (OMMU), patient registry and ID card guidance (Chapter 64-4, F.A.C.)
- National Academies of Sciences, Engineering, and Medicine (2017). The Health Effects of Cannabis and Cannabinoids.
- FDA: cannabis-derived drug approvals and cannabis regulatory status
- 18 U.S.C. § 922(g)(3) and ATF Form 4473 (firearms)
Medical cannabis is regulated under Florida Statute §381.986 and is not approved by the FDA for the treatment of any condition. The clinical evidence varies substantially by condition. Side effects and drug interactions exist and are discussed during evaluation. Cannabis remains a federally controlled Schedule I substance. This page is informational and does not substitute for a clinical visit. See Fla. Stat. § 381.986 and the Florida Department of Health, Office of Medical Marijuana Use (Chapter 64-4, F.A.C.).